会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • HEAT GENERATING NANOMATERIALS
    • 热发生纳米材料
    • WO2009142438A2
    • 2009-11-26
    • PCT/KR2009/002661
    • 2009-05-20
    • INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITYCHEON, Jin WooJANG, Jung Tak
    • CHEON, Jin WooJANG, Jung Tak
    • C09K5/14
    • C09K5/14A61K9/5115A61K41/0052A61N1/406
    • The present invention relates to a heat-generating composition, comprising a hetero-structure nanomaterial which comprises (a) a first material comprising at least one component selected from the group consisting of a metal, a metal chalcogen, a metal pnicogen, an alloy and a multi-component hybrid structure thereof; and (b) a second material comprising at least one component selected from the group consisting of metal, metal chalcogen, metal pnicogen, alloy and the multi-component hybrid structure thereof; wherein the first material is enclosed in the second material; wherein at least one of the first material and the second material comprise a magnetic material. The specific loss power of the present nanomaterial is much higher than that of conventional nanomaterials ( e.g. , 40-fold higher than commercially accessible Feridex) and may be controlled by changing compositions or ratios of the first material and/or the second material. The heat-generating nanomaterial of the present invention may be used in a variety of application fields, for example cancer hyperthermia.
    • 本发明涉及一种发热组合物,其包含异质结构纳米材料,其包含(a)第一材料,其包含选自金属,金属硫族元素,金属原子,合金和 其多组分杂化结构; 和(b)包含选自金属,金属硫属元素,金属致癌剂,合金及其多组分混合结构中的至少一种成分的第二材料; 其中所述第一材料被封闭在所述第二材料中; 其中所述第一材料和所述第二材料中的至少一个包括磁性材料。 本纳米材料的特定损耗功率远高于常规纳米材料(例如,比商业上可接受的Feridex高40倍),并且可以通过改变第一材料和/或第二材料的组成或比例来控制。 本发明的发热纳米材料可以用于各种应用领域,例如癌症高热。
    • 3. 发明申请
    • METHODS FOR CONTROLLING HEAT GENERATION OF MAGNETIC NANOPARTICLES AND HEAT GENERATING NANOMATERIALS
    • 用于控制磁性纳米粒子的热生成和热生成纳米材料的方法
    • WO2009142439A2
    • 2009-11-26
    • PCT/KR2009/002662
    • 2009-05-20
    • INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITYCHEON, Jin WooJANG, Jung Tak
    • CHEON, Jin WooJANG, Jung Tak
    • B82B3/00
    • A61K41/0052A61K9/5094
    • The present invention relates to a method for controlling heat generation of a magnetic nanomaterial, comprising the steps of: (a) mixing (i) a nanomaterial precursor comprising a metal precursor material and a predetermined amount of a zinc precursor with (ii) a reaction solvent; and (b) preparing a zinc-containing magnetic nanomaterial from the mixture of step (a) comprising a zinc doped metal oxide nanomaterial matrix; and wherein a specific loss power of the zinc-containing magnetic nanomaterial is varied depending an amount of zinc to be doped, whereby the heat generation of the magnetic nanomaterial is controlled. In addition, the present invention relates to a heat-generating nanoparticle and a composition for hyperthermia. The present invention suggests a novel approach to improve a heat generation of a magnetic nanomaterial. According to the present invention, the specific loss power can be controlled by changing a zinc-content to be introduced into nanomaterials and therefore a composition for hyperthermia showing controlled heat generation potential can be successfully provided.
    • 本发明涉及一种用于控制磁性纳米材料的发热的方法,包括以下步骤:(a)将(i)包含金属前体材料和预定量的锌前体的纳米材料前体与(ii)反应 溶剂; 和(b)从包含锌掺杂金属氧化物纳米材料基质的步骤(a)的混合物制备含锌磁性纳米材料; 并且其中所述含锌磁性纳米材料的特定损耗功率随着待掺杂的锌的量而变化,由此控制所述磁性纳米材料的发热。 另外,本发明涉及发热性纳米粒子和热疗用组合物。 本发明提出了改进磁性纳米材料的发热的新方法。 根据本发明,可以通过改变要引入纳米材料的锌含量来控制比损失功率,因此可以成功地提供显示受控制热势的热疗组合物。
    • 6. 发明申请
    • NANOPARTICLES FOR PENETRATION OF BLOOD-BRAIN BARRIER
    • 用于血液透析的纳米颗粒
    • WO2009136763A2
    • 2009-11-12
    • PCT/KR2009/002440
    • 2009-05-08
    • INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITYCHEON, Jin WooLEE, Jae-Hyun
    • CHEON, Jin WooLEE, Jae-Hyun
    • B82B3/00
    • A61K49/1863A61K49/1857A61K49/1869B82Y5/00
    • The present invention relates to (a) a nanoparticle for penetration of a blood-brain barrier (BBB) comprising an inorganic nanoparticle core and a water-soluble multi-functional organic ligand coated on the nanoparticle core, and (b) a composition for brain imaging and (c) a pharmaceutical composition for brain-targeting thereof. The basic strategy adopted in the present invention is based on the finding that the water-soluble multi-functional organic ligand coated on the nanoparticle core permits the nanoparticle to penetrate the blood-brain barrier. The nanoparticle of the present invention may be efficiently used as a brain-imaging agent and in a drug delivery system into brain since the inorganic nanoparticle core coated with the water-soluble multi-functional organic ligand ensures an effective penetration of the blood-brain barrier even with no use of conventional adjuvants.
    • 本发明涉及(a)包含无机纳米颗粒核心和涂覆在纳米颗粒核心上的水溶性多官能有机配体的血脑屏障(BBB)的渗透纳米颗粒,和(b)脑组合物 成像和(c)用于脑靶向它的药物组合物。 本发明中采用的基本策略是基于以下发现:涂覆在纳米颗粒核上的水溶性多官能有机配体允许纳米颗粒穿透血脑屏障。 本发明的纳米颗粒可以有效地用作脑显像剂和药物递送系统进入脑部,因为涂覆有水溶性多功能有机配体的无机纳米颗粒核心确保了血脑屏障的有效穿透 即使没有使用常规的佐剂。
    • 7. 发明申请
    • T1-T2 DUAL MODAL MRI CONTRAST AGENTS
    • T1-T2双模式MRI对比剂
    • WO2010021519A2
    • 2010-02-25
    • PCT/KR2009/004683
    • 2009-08-21
    • INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITYCHEON, Jin WooCHOI, Jin-Sil
    • CHEON, Jin WooCHOI, Jin-Sil
    • A61K49/06
    • A61K49/1869A61K49/183A61K49/1836A61K49/1854A61K49/1857A61K49/1863B82Y5/00
    • The present invention relates a T1-T2 dual-modal MRI (magnetic resonance imaging) contrast agent, comprising (a) a first layer consisting of T1 contrast material; (b) a second layer consisting of T2 contrast material; and (c) a separating layer which is present in a space between the first layer and the second layer, and inhibits a reciprocal interference between T1 contrast material and T2 contrast material, and a heat-generating composition and a drug delivery composition having the same. The T1-T2 dual-modal contrast agent of the present invention may generate both T1 and T2 signal and thus observe the signal complementarily, resulting in accurate diagnosis through reduction of misdiagnosis. Further, T1 and T2 MR imaging may be simultaneously obtained by simple operation within the same MR imaging device, enabling to remarkably reduce a diagnosis time and diagnosis cost. In addition, the particle constituting the T1-T2 dual-modal contrast agent of the present invention may be applied to hyperthermia and drug delivery systems.
    • 本发明涉及一种T1-T2双模态MRI(磁共振成像)造影剂,其包括(a)由T1对比材料组成的第一层; (b)由T2造影材料组成的第二层; 和(c)分离层,其存在于第一层和第二层之间的空间中,并且抑制T1造影材料与T2造影剂材料之间的相互干涉,以及发热组合物和具有其的药物递送组合物 。 本发明的T1-T2双模造影剂可以产生T1和T2信号,从而互补地观察信号,从而通过减少误诊来进行准确的诊断。 此外,可以通过在同一MR成像装置内的简单操作同时获得T1和T2 MR成像,从而显着地减少诊断时间和诊断成本。 此外,构成本发明的T1-T2双模造影剂的颗粒可以应用于高热和药物输送系统。